Patents by Inventor Lars Kärnerud

Lars Kärnerud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100173884
    Abstract: The invention relates to the use of a composition comprising an oil-extract and a water-soluble extract, wherein said extracts are obtainable from plant materials and said extracts comprise phytosterols, for the manufacturing of a medicament for the treatment of females suffering from LUTS as a consequence of Interstitial Cystitis and/or stress or urge incontinence.
    Type: Application
    Filed: December 6, 2007
    Publication date: July 8, 2010
    Applicant: Natumin Pharma AB
    Inventors: Lars Kärnerud, Arata Paul Yamasaki, Claus Tufvesson
  • Patent number: 6669967
    Abstract: A method for the treatment of disorders related to normal hormonal variations in women during fertile, peri- and post-menopausal age, by the administering of a composition comprising, as active ingredients, a water and/or fat-soluble cytosolic extract of pollen and optionally pistils, optionally combined with Royal Jelly and vitamin E.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: December 30, 2003
    Assignee: Natumin Pharma AB
    Inventors: Kaj Winter, Christer Hedman, Lars Kärnerud
  • Patent number: 6569471
    Abstract: A method for the treatment of symptoms related to normal hormonal variations in women during fertile, peri- and post-menopausal age, by the administering of a composition comprising, as active ingredients, a water and/or fat-soluble cytosolic extract of pollen, optionally combined with Royal Jelly and Vitamin E.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: May 27, 2003
    Assignee: Natumin Pharma AB
    Inventors: Kaj Winther, Christer Hedman, Lars Kärnerud
  • Patent number: 6406708
    Abstract: The invention relates to a composition comprising, from 2 to 8% squalane, from 1.5 to 8% cyclodextrin, and from 1.5 to 8% of a pharmaceutically and/or cosmetically acceptable acid selected from aliphatic mono-, di- and &agr;-hydroxy carboxylic acids having from 2 to 10 carbon atoms, and the balance selected from other pharmaceutically and/or cosmetically acceptable compatible anti-acne active substances as well as pharmaceutically and/or cosmetically acceptable paste, ointment or cream bases and additives. The composition has therapeutic and cosmetic effect and can be used as a cosmetic as well as for the preparation of a drug for prophylactic and curative treatment of acne. A method for the preparation of the composition as well as a method for treatment of acne is also included in the invention.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: June 18, 2002
    Assignee: Interhealth AB
    Inventors: Lars Kärnerud, Stellan Ölmeskog